Could a tiny sensor replace the glucose drink test for new moms?

NCT ID NCT06184373

Recruiting now Knowledge-focused Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a continuous glucose monitor (CGM) — a small sensor worn under the skin — is an acceptable and useful tool for checking diabetes risk in women who recently had gestational diabetes. Twenty women will wear the CGM for 10 days at 6-8 weeks after giving birth, then complete surveys about their experience. The goal is to see if CGM could improve low follow-up rates for postpartum diabetes screening.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: continuous glucose monitor (CGM)
What this could lead to: If successful, this could show that CGM is a practical and acceptable way to screen for diabetes risk after gestational diabetes, potentially improving follow-up care.
What could go wrong: This is a very small early study (20 participants) focused on acceptability, not on proving that CGM prevents diabetes. Results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes hyperglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES HYPERGLYCEMIA

Contacts and locations

Locations

Ohio State University Medical Center
RECRUITING

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.